Trulieve Cannabis (TCNNF) EPS (Weighted Average and Diluted) (2020 - 2026)

Trulieve Cannabis' EPS (Weighted Average and Diluted) history runs 7 years deep, the most recent figure standing at $0.02 for Q1 2026.

• In Q1 2026, EPS (Weighted Average and Diluted) rose 112.5% year-over-year to $0.02; the TTM figure through Mar 2026 stood at -$0.39 (up 50.63% YoY), while the FY2025 annual figure was -$0.58, up 26.58% from the prior year.
• EPS (Weighted Average and Diluted) was $0.02 for Q1 2026 at Trulieve Cannabis, up from -$0.23 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.02 in Q1 2026 to a low of -$1.8 in Q2 2023.
• Historically, EPS (Weighted Average and Diluted) has averaged -$0.27 across 5 years, with a median of -$0.16 in 2022.
• The sharpest annual moves came in 2023 and 2026: EPS (Weighted Average and Diluted) sank 1900.0% in 2023, then soared 112.5% in 2026.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.32 in 2022, then surged by 40.63% to -$0.19 in 2023, then tumbled by 42.11% to -$0.27 in 2024, then advanced by 14.81% to -$0.23 in 2025, then jumped by 108.7% to $0.02 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.02 (Q1 2026), -$0.23 (Q4 2025), and -$0.11 (Q3 2025), per Business Quant data.